Investing in the Analytical Methods & Facilities for the Future of Live Biotherapeutic Products

Time: 10:05 am
day: Day One


  • As an increasing number of Live Biotherapeutic Products move through clinical trials to commercialization, there is a growing need for more advanced analytical methods to characterize drug substance and drug product, establish CQAs, and ensure process control
  • Facility design is instrumental to product purity and quality and contributes greatly to a smooth regulatory approval
  • Investing in analytics and facility design to help bring therapies to patients